Abstract:Triple negative breast cancer (TNBC) is a subtype of breast cancer with poorest survival outcome and is prone to metastasis. TUFT1 and the long non-coding RNA (lncRNA), DANCR, play vital roles in metastasis and progression of various cancers. However, the correlation between TUFT1 and DANCR in TNBC and their downstream molecular mechanisms are still undetermined. We demonstrated that upregulation of TUFT1 in TNBC is related to a worse survival in TNBC patients. The TNBC cells invasiveness was augmented by TUFT1 in a dose-dependent manner, while inhibiting TUFT1 repressed the invasiveness. Particularly, the expression of TUFT1 was positively correlated with the expression of DANCR in TNBC tissues. In addition, TUFT1 increased DANCR expression, while silencing DANCR ameliorated the invasiveness of TNBC cells induced TUFT1. As demonstrated, TUFT1 interacted with miR-874-3p. Subsequently, qRT-PCR together with luciferase reporter further demonstrated that TUFT1 acted as competing endogenous (ceRNA) for miR-874-3p, thereby regulating the de-repression of SOX2 and advancing epithelial–mesenchymal transition (EMT) in TNBC. The present research shows that TUFT1 promote the malignant development in TNBC via enhancing the expression of DANCR. The upregulation of DANCR may contribute to the progression and tumor invasiveness of TNBC, considering that DANCR functions as a miR-874-5p sponge, thus modulating SOX2 positively. Collectively, the present study explored the molecular mechanism underlying TUFT1 in TNBC, raising a TUFT1-mediated therapy for the treatment of patients with TNBC.Funding Statement: This work was supported by the National Natural Science Foundation of China (No.81371259, No.81471352, No.81641160); the Natural Science Foundation of Guangdong Province, China (No.2016A030313251; No.2018A0303130272); the Science and Technology Planning Project of Guangzhou, China (No. 201707010207). Declaration of Interests: The authors have no conflict of interest.Ethics Approval Statement: All human samples were collected with informed consents from the donors according to the International Ethical Guidelines for Biomedical Research Involving Human Subjects (CIOMS). The study was carried out with the approval of the institutional review board (IRB) of Sun Yat-Sen Memorial Hospital.All experimental procedures and protocols in this study were approved by the animal care committee at Sun Yat-sen University, Guangzhou, China, and were performed in strict accordance with National Institutes of Health Guidelines for the use of experimental animals.

STAT3-induced HLA-F-AS1 Promotes Cell Proliferation and Stemness Characteristics in Triple Negative Breast Cancer Cells by Upregulating TRABD.

A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple‐negative breast cancer

SP1-Induced Upregulation of LncRNA AFAP1-AS1 Promotes Tumor Progression in Triple-Negative Breast Cancer by Regulating mTOR Pathway

TCF3-activated FAM201A Enhances Cell Proliferation and Invasion Via Mir-186-5p/tnks1bp1 Axis in Triple-Negative Breast Cancer

Long Non-Coding RNA MNX1-AS1 Promotes Progression of Triple Negative Breast Cancer by Enhancing Phosphorylation of Stat3

PBX3-activated DLG1-AS1 Can Promote the Proliferation, Invasion and Migration of TNBC Cells by Sponging Mir-16-5p

BTF3 Promotes Stemness and Inhibits TypeⅠInterferon Signaling Pathway in Triple-Negative Breast Cancer.

Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway

Long Non-Coding Rna Lrrc75a-As1 Facilitates Triple Negative Breast Cancer Cell Proliferation And Invasion Via Functioning As A Cerna To Modulate Baalc

LncRNA HIF1A-AS2 promotes triple-negative breast cancer progression and paclitaxel resistance via MRPS23 protein

TGFB2-AS1 Inhibits Triple-Negative Breast Cancer Progression Via Interaction with SMARCA4 and Regulating Its Targetstgfb2andsox2

Exploring the Regulatory Role of FBXL19-AS1 in Triple-Negative Breast Cancer Through the Mir-378A-3p/otub2 Axis

LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway

LncRNA BRE-AS1 Acts As a Tumor Suppressor Factor in Bladder Cancer Via Mediating STAT3.

TUFT1-Induced LncRNA DANCR Upregulation Promotes Malignant Progression in Triple Negative Breast Cancer Via Mir-874-3p-sox2 Axis

Mir-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A

STAT3: Key targets of growth-promoting receptor positive breast cancer

Long Noncoding RNA DCST1-AS1 Promotes Cell Proliferation and Metastasis in Triple-negative Breast Cancer by Forming a Positive Regulatory Loop with miR-873-5p and MYC

HOXD Antisense Growth-Associated Long Noncoding RNA Promotes Triple-Negative Breast Cancer Progression by Activating Wnt Signaling Pathway

LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Downregulating Transforming Growth Factor β1.

STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review